Nature Communications (Nov 2022)

Lipidomic signatures align with inflammatory patterns and outcomes in critical illness

  • Junru Wu,
  • Anthony Cyr,
  • Danielle S. Gruen,
  • Tyler C. Lovelace,
  • Panayiotis V. Benos,
  • Jishnu Das,
  • Upendra K. Kar,
  • Tianmeng Chen,
  • Francis X. Guyette,
  • Mark H. Yazer,
  • Brian J. Daley,
  • Richard S. Miller,
  • Brian G. Harbrecht,
  • Jeffrey A. Claridge,
  • Herb A. Phelan,
  • Brian S. Zuckerbraun,
  • Matthew D. Neal,
  • Pär I. Johansson,
  • Jakob Stensballe,
  • Rami A. Namas,
  • Yoram Vodovotz,
  • Jason L. Sperry,
  • Timothy R. Billiar,
  • PAMPer study group

DOI
https://doi.org/10.1038/s41467-022-34420-4
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 18

Abstract

Read online

Alterations in lipid metabolism and circulating lipid species have been reported in patients with acute critical illness. Here the authors show that selective rise in systemic phosphatidylethanolamine levels is a common feature of critical illness that associates with worse clinical outcomes.